en English


October 1, 2021

NSW Health & Medical Research | NSW spearheads key COVID-19 vaccine research

A leading group of NSW experts will pioneer Australia-first research to inform vaccine policy in the state and beyond. The Vaccine, Infection and Immunology (VIIM) Collaborative Research Group will receive more than $4.5 million in funding from the NSW Government over three years to study the clinical and immunological responses to COVID-19 vaccines in NSW...

Read More

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. We aim to foster a culture of excellence through collaboration with industry experts and thought leaders to deliver better outcomes.